Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study.
暂无分享,去创建一个
M. Dreyling | S. Schuster | C. Andreadis | M. Dickinson | C. Thieblemont | N. Fowler | M. Ghosh | R. Tiwari | A. Chen | Aisha Masood | R. Ramos | E. Jousseaume